News
Earnings Preview: LyondellBasell (LYB) Q3 Earnings Expected to Decline
LyondellBasell (LYB) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook
Linde (LIN) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Linde (LIN) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Magna (MGA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
The market expects Magna (MGA) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook is
Earnings Preview: Marcus (MCS) Q3 Earnings Expected to Decline
The market expects Marcus (MCS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook is
Earnings Preview: Lear (LEA) Q3 Earnings Expected to Decline
Lear (LEA) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a
Imperial Oil (IMO) Expected to Beat Earnings Estimates: Should You Buy?
Wall Street expects a year-over-year decline in earnings on higher revenues when Imperial Oil (IMO) reports results for the quarter ended September 2025. While this widely-known consensus outlook
W.W. Grainger (GWW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects W.W. Grainger (GWW) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Canadian National (CNI) Earnings Expected to Grow: Should You Buy?
Canadian National (CNI) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Earnings Preview: Chevron (CVX) Q3 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Chevron (CVX) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Earnings Preview: Church & Dwight (CHD) Q3 Earnings Expected to Decline
The market expects Church & Dwight (CHD) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Cenovus Energy (CVE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Cenovus Energy (CVE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook
Earnings Preview: Dominion Energy (D) Q3 Earnings Expected to Decline
The market expects Dominion Energy (D) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Analysts Estimate Colgate-Palmolive (CL) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when Colgate-Palmolive (CL) reports results for the quarter ended September 2025. While this widely-known consensus
Aon (AON) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Aon (AON) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook is
Best Momentum Stocks to Buy for Oct. 24
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 24:
Avino Silver & Gold Mines Ltd. ASM: This mining company has a Zacks Rank #1 and
Incyte Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
We expect Incyte Corporation INCY to surpass expectations when it reports third-quarter 2025 earnings on Oct. 28, before the opening bell. The Zacks Consensus Estimate for the to-be-reported
REGN Q3 Earnings: Will Higher Dupixent Profits Offset Eylea Sales Decline?
Investors will focus on profits from asthma drug Dupixent and sales of Eylea HD when biotech giant Regeneron Pharmaceuticals, Inc. REGN reports third-quarter 2025 results on Oct. 28, 2025.
The Zacks
General Dynamics' Q3 Earnings Surpass Estimates, Revenues Improve Y/Y
General Dynamics Corporation GD reported third-quarter 2025 earnings per share (EPS) of $3.88, which beat the Zacks Consensus Estimate of $3.73 by 4%. The bottom line also increased 15.8% from $3.35
Wall Street Analysts See a 38.92% Upside in Dutch Bros (BROS): Can the Stock Really Move This High?
Shares of Dutch Bros (BROS) have gained 7.1% over the past four weeks to close the last trading session at $57.14, but there could still be a solid upside left in the stock if short-term price
Does Orla Mining (ORLA) Have the Potential to Rally 48.95% as Wall Street Analysts Expect?
Orla Mining Ltd. (ORLA) closed the last trading session at $10.95, gaining 4.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
Omnicell (OMCL) closed the last trading session at $30.89, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Can CTO Realty (CTO) Climb 28.19% to Reach the Level Wall Street Analysts Expect?
CTO Realty (CTO) closed the last trading session at $16.32, gaining 2.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Think Delta (DAL) Could Surge 25.22%: Read This Before Placing a Bet
Shares of Delta Air Lines (DAL) have gained 3.6% over the past four weeks to close the last trading session at $58.77, but there could still be a solid upside left in the stock if short-term price
How Much Upside is Left in Cognizant (CTSH)? Wall Street Analysts Think 25.68%
Cognizant (CTSH) closed the last trading session at $68.03, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts See a 29.28% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?
Shares of Amylyx Pharmaceuticals, Inc. (AMLX) have gained 3.6% over the past four weeks to close the last trading session at $14.31, but there could still be a solid upside left in the stock if